Delivery Order SPE2DR25D2104-SPE2DR26F3VCU
Award Date 2/4/26
Potential Completion Date 2/5/26
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $6,836.70 for RINVOQ ER 30 mg tablets (30-count). Place of performance is Conshohocken, PA. Ultimate completion date is February 6, 2026. The order was issued under firm fixed-price terms with no set-aside. Amerisourcebergen Drug Corp operates under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $11,862.59 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on January 13, 2026, with completion scheduled for January 14, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $3,279.20. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 26, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units) on January 22, 2026, with a contract ceiling value of $11,571.44 and an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the corporate headquarters for AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $9,837.60 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packaging) on January 28, 2026, with completion anticipated by January 29, 2026. This is a firm fixed-price, non-set-aside contract awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc. (doing business as AmerisourceBergen)...
- The Defense Logistics Agency awarded a delivery order valued at $11,359.23 to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of RINVOQ ER 30 mg tablets in units of 30. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for RINVOQ ER 45 mg tablets (28-tablet unit of use) with a ceiling value of $7,483.54. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026, enabling supply of pharmaceutical products and medical supplies to military healthcare...
- On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $3,279.32 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count unit dose). The contract is a firm fixed-price delivery order with an ultimate completion date of January 15, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora,...
- The Defense Logistics Agency issued a $26,661.26 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for RINVOQ ER 15 mg tablets (30-count unit dose packaging). The order is issued under an Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. This vehicle supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries...
- On February 3, 2026, the Defense Logistics Agency awarded a delivery order valued at $7,822.48 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 45 MG tablets (28-count unit of use packaging). This firm fixed-price delivery order, with an ultimate completion date of February 4, 2026, was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent...